Overview

A Study to Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients

Status:
Terminated
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
A study to evaluate the safety and efficacy of Prograf/FK778 in de novo kidney transplant patients
Phase:
Phase 2
Details
Lead Sponsor:
Astellas Pharma Inc
Collaborator:
Astellas Pharma US, Inc.
Treatments:
Tacrolimus